ENFLONSIA 150 mg/mL
CLESROVIMAB · INJECTION, SOLUTION · Merck Sharp & Dohme LLC
No Recall History
Plain English
ENFLONSIA is a injection, solution containing clesrovimab at 150 mg/mL, taken intramuscular. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- ENFLONSIA
- Generic Name
- CLESROVIMAB
- NDC Code (Product)
0006-5073- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 150 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA761432
- Drug Class
- Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]
- Marketing Start
- 06/09/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is ENFLONSIA used for?
ENFLONSIA contains CLESROVIMAB. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is ENFLONSIA a controlled substance?
ENFLONSIA is not classified as a controlled substance by the DEA.
What is the generic name for ENFLONSIA?
The generic name for ENFLONSIA is CLESROVIMAB. There are no other listed brand versions of CLESROVIMAB.
What is the NDC code for ENFLONSIA 150 mg/mL?
The NDC (National Drug Code) for ENFLONSIA 150 mg/mL is 0006-5073, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)